Skip to main content

Table 1

From: Genotypic susceptibility to tipranavir of HIV-1 isolates in treatment-experienced patients

 

Genotypic TPV susceptibility* (n = 139)

Phenotypic TPV susceptibility** (n = 69)

Overall

58%

79%

1–2 previous PIs

83%

90%

3–4 previous PIs

60%

71%

5+ previous PIs

36%

52%

  1. *includes only full susceptibility
  2. **includes full and partial susceptibility